
Diagnostic and pharmaceutical product manufacturers

In September, the National Medical Products Administration approved the registration of Abbott's Alinity m automated nucleic acid analysis system in China, officially granting it market approval (Registration No. 20243220544).

Alinity m made its debut in China at the 4th CIIE in 2021 and obtained certification three years later, demonstrating Abbott's high registration efficiency.

(Click on the "Read Original" at the end of the article to enter the 3D demo)

ReadiFlex Technology - Abbott's proprietary technology that enables true random access (completed without affecting turnaround time or throughput)

Universal Sample Rack — No sample sorting required, simplifies front-end workflow, up to 12 racks, 144 samples
To optimize sample extraction, RNA and DNA specific extraction and purification reagents have been developed to achieve better PCR performance while reducing manual handling time.

Within ~8 hours, there are 75 opportunities to start a new test - including STAT samples, with the time to first result being <115 minutes, and obtaining 300 results within 8 hours.

A maximum of 20 test items can be performed at one time.



To facilitate communication and exchange among the readers and fans of the In Vitro Diagnostics Network, we have specially established the 159th In Vitro Diagnostics Network group in China! Everyone is welcome to scan the QR code below and join the group to participate actively in discussions!


